Today's Top 5
5. Targeted Therapies in MDS
Now online @MDStanch, @TaylorJ_MD and colleagues from @SylvesterCancer review article "Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS)" #MDSsm #leusm #hematology 👉https://t.co/Fu1va77yPB pic.twitter.com/8hRkGVR42m
— Hemato MDPI (@Hemato_MDPI) May 6, 2021
4. ASCO President: Foster More Inclusive Cancer Research
"...We need to think of diverse #clinicaltrials as an antidote to the effects of racism, not an accounting for race. I urge all of us to speak boldly—but thoughtfully—about this imperative in our efforts to foster more inclusive cancer research." @ASCOPres in @MedscapeOnc https://t.co/vYCLEhXPvA
— ASCO (@ASCO) May 7, 2021
3. Multidisciplinary Care for Pancreatic Cancer
If you're not discussing your pancreatic cancer patients in multidisciplinary fashion you are under-serving them
— Mark Lewis (@marklewismd) May 7, 2021
Tumor boards optimize outcomes#pancsm #GDUGI2021 #medtwitter
2. Advocating for a Sickle Cell Registry
.@DrTitiFasipe and @andreharris89 are doing great things here in Texas for people with #SickleCell https://t.co/xFcXabLAjJ
— Amber M Yates, MD (@sicklecelldoc) May 10, 2021
1. Combination Therapy for Triple-Negative Breast Cancer
#ESMOBreast21@MOliveira000 discusses the high promises of combinations of #ADCs + #immune therapy and #bispecific antibodies in #TNBC#SaciIO #ladiratuzumab #IntrapidBreast@myESMO @OncoAlert #bcsm pic.twitter.com/dTyuJyVRhT
— Kevin Punie (@kevinpunie) May 8, 2021